Suspended

Perioperative Gut Microbiota and Post-operative Ileus in Colorectal Cancer Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected from past medical records and data - Retrospective
DNA Samples
Who is being recruted

From 35 to 80 Years
+14 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Case-Control

Comparing exposures between individuals with and without disease in order to identify potential risk factors.
Observational
Study Start: April 2019
See protocol details

Summary

Principal SponsorFirst Affiliated Hospital of Harbin Medical University
Study ContactYunwei Wei, professorMore contacts
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: April 1, 2019

Actual date on which the first participant was enrolled.

This study focuses on understanding postoperative ileus (POI), a common condition that can occur after abdominal surgery, particularly in patients with colorectal cancer. POI can cause symptoms such as abdominal swelling, nausea, vomiting, and difficulty passing stools, leading to extended hospital stays and increased risk of complications. The exact cause of POI is still unclear, but researchers believe that changes in gut bacteria during the surgery period may contribute to this condition. This study aims to explore how the gut microbiome of colorectal cancer patients changes during the time of surgery, and how these changes might be linked to POI. During the study, the composition of gut bacteria in colorectal cancer patients will be analyzed using advanced sequencing techniques. The study will compare changes in gut bacteria between two groups of patients. The primary outcomes of the study include understanding the diversity and structure of gut bacteria, as well as identifying specific types of bacteria that might be associated with POI. The study will also measure the time it takes for patients to have their first bowel movement after surgery, as this is an important indicator of gut recovery.

Official TitlePost-operative Ileus of Colorectal Cancer Patients Associated With Perioperative Gut Microbiota
NCT04009954
Principal SponsorFirst Affiliated Hospital of Harbin Medical University
Study ContactYunwei Wei, professorMore contacts
Last updated: January 27, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

40 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-Control

These studies compare people who have a disease (cases) with those who don't (controls). The goal is to look back at previous exposures or risk factors to identify what might have contributed to the disease.


Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

From 35 to 80 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Criteria

3 inclusion criteria required to participate
Requirements of informed consent and assent of participant, parent or legal guardian as applicable

Patients with colorectal cancer scheduled for radical coloproctectomy and between the age of 35 and 80 years old without considering sex.

Patients with BMI= 18.5-23.9

11 exclusion criteria prevent from participating
Patients with colorectal cancer with distant metastasis

Chronic renal diseases and hepatic cirrhosis

Chronic ischemic heart disease with unstable angina, chronic heart failure at class III or IV and acute myocardial infarction in the last 6 months

Individuals with a history of Chronic diarrhea

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Recruiting

First affiliated hospital of Harbin medical university

Harbin, ChinaOpen First affiliated hospital of Harbin medical university in Google Maps
SuspendedOne Study Center
Perioperative Gut Microbiota and Post-operative Ileus in Colorectal Cancer Patients | PatLynk